Skip to content
New platform coming soon — AI-Based Analysis with Human-Generated Insights
Stock Target Advisor Stock Target Advisor Market intelligence
  • Research ▾
    • Equity Reports
    • STA Portfolio
    • Top Stocks
  • Market Analysis
  • Analyst Ratings
  • Stock Research Tools ▾
    • Analyst Target Tool
    • Analyst Ranking Tool
    • Stock Analysis Tool
  • About ▾
    • About STA
    • Services
    • Contribute
    • Contact
  • Social Media ▾
    • YouTube
    • Blossom
    • Substack
    • TikTok

Browse research

Tag: U.S. Markets

Is Bitcoin's Bull Run Signaling a Top in Stock Markets?
Market News & Insights Nov 14, 2024

Is Bitcoin’s Bull Run Signaling a Top in Stock Markets?

Bitcoin & Financial Markets Bitcoin has experienced a significant surge in value, with the cryptocurrency reaching levels not seen since its 2021…

#interest rates #Market Analysis #Mining Stocks
AppLovin Corp:
Market News & Insights Nov 8, 2024

AppLovin’s Q3 Earnings Propel Stock to Soar Over 46% – What Investors Need to Know

AppLovin Corp (APP) stock surged by more than 46% following the release of its third-quarter earnings and updated guidance, significantly surpassing Wall…

#Earnings #etfs #technology stocks
Copa Holdings (CPA)
Market News & Insights Nov 8, 2024

Is Copa Holdings (CPA) Stock Undervalued? Analysts See a 52.5% Potential Upside

Copa Holdings SA (CPA) has captured significant investor interest, bolstered by strong fundamentals and a robust financial track record. As an airline…

#analyst ratings #Earnings #etfs
Canadian Analyst Updates: Sept 16th, 2026
Market News & Insights Nov 8, 2024

Barrick Gold Corp Q3 Earnings: Fundamental Analysis is Slightly Bullish

Barrick Gold (ABX:CA) (GOLD) Barrick Gold Corp (GOLD) – Q3 2024 Earnings Analysis Barrick Gold Corp’s third-quarter earnings missed analyst expectations, primarily…

#analyst ratings #Canadian Markets #Earnings
Esperion Therapeutics
Market News & Insights Nov 7, 2024

Esperion Therapeutics (ESPR) Q3 2024 Financials: Key Highlights and Future Outlook

Esperion Therapeutics Inc (ESPR) recently reported its financial results for Q3 2024, showcasing a solid revenue increase and notable developments in its…

#Earnings #etfs #Healthcare Stocks

Posts pagination

Previous 1 … 23 24 25 26 27 … 83 Next
Stock Target Advisor

Timely market news, analyst rating changes, and practical investment research for investors around the world.

  • Research
  • Analyst Ratings
  • Market Analysis
  • Top Stocks
  • About Us
  • Contact Us
  • Contribute a Post
© 2026 Stock Target Advisor. All rights reserved.

STA RESEARCH

Get the STA Research Professional Newsletter

Market outlook, portfolio updates, technical analysis and stock ideas—US$5/month.

See What’s Included →

Monthly subscription. Secure checkout with PayPal.